Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Galantamine prolonged-release formulation in the treatment of mild to moderate Alzheimer's disease.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Galantamine prolonged-release formulation in the treatment of mild to moderate Alzheimer's disease.
Galantamine prolonged-release formulation in the treatment of mild to moderate Alzheimer's disease. Dement Geriatr Cogn Disord. 2005; 20(2-3):120-32.
View in:
PubMed
subject areas
Activities of Daily Living
Aged
Aged, 80 and over
Alzheimer Disease
Behavior
Cholinesterase Inhibitors
Delayed-Action Preparations
Double-Blind Method
Endpoint Determination
Female
Galantamine
Humans
Male
Middle Aged
Psychiatric Status Rating Scales
authors with profiles
Michael R. Gold